MCC950 ameliorates ventricular arrhythmia vulnerability induced by heart failure

MCC950, a specific NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inhibitor, has been reported to play a role in various cardiovascular diseases. However, its role in heart failure (HF)-induced ventricular arrhythmias (VAs) remains unclear. Hence, the present study aimed to clarify the rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaobo, Yang, Fan, Ou, Dengke, Huang, Luyong, Li, Hongfei, Lang, Mingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162026/
https://www.ncbi.nlm.nih.gov/pubmed/35287557
http://dx.doi.org/10.1080/21655979.2022.2053813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162026/
https://www.ncbi.nlm.nih.gov/pubmed/35287557
http://dx.doi.org/10.1080/21655979.2022.2053813

Ejemplares similares